Peng Du

704 total citations
32 papers, 438 citations indexed

About

Peng Du is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Peng Du has authored 32 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Peng Du's work include Gastric Cancer Management and Outcomes (4 papers), Cancer Risks and Factors (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Peng Du is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Cancer Risks and Factors (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Peng Du collaborates with scholars based in China, United States and Italy. Peng Du's co-authors include Jingting Jiang, Zhuo Hao, Kuiyu Wang, Jiayu Wan, Changtian Li, Shengjun Bu, Wensen Liu, Yuqi Shi, Xiao-Dong Li and Zhibin Cheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Peng Du

30 papers receiving 436 citations

Peers

Peng Du
Qing Guo China
Ke Zhu China
Mengxi Sun China
Bing Lin China
Mengzhao Zhang China
Yanyang Nan China
Jiayi Li China
Longfei Deng China
Guiying Zhang China
Qing Guo China
Peng Du
Citations per year, relative to Peng Du Peng Du (= 1×) peers Qing Guo

Countries citing papers authored by Peng Du

Since Specialization
Citations

This map shows the geographic impact of Peng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Du more than expected).

Fields of papers citing papers by Peng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Du. The network helps show where Peng Du may publish in the future.

Co-authorship network of co-authors of Peng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Du. A scholar is included among the top collaborators of Peng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Du. Peng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Peng, et al.. (2025). Full-endoscopic posterior lumbar interbody fusion for the treatment of lumbar degenerative diseases: a technical note with 2-year follow-up. Journal of Orthopaedic Surgery and Research. 20(1). 286–286. 2 indexed citations
2.
Shi, Guoqing, et al.. (2024). Association between different patterns of obesity and the short-term outcomes of gastric cancer surgery. European Journal of Cancer Prevention. 34(5). 436–444. 1 indexed citations
3.
Gao, Tianyu, et al.. (2024). Association between chemotherapy for surgically treated rectal cancer and second primary endometrial cancer. Scientific Reports. 14(1). 18730–18730.
4.
Liu, Jia, Shenghan Wang, Yong Yang, et al.. (2024). Real-world retrospective study of prostate-specific antigen and safety assessment with darolutamide plus androgen deprivation therapy for metastasis hormone-sensitive prostate cancer. Translational Andrology and Urology. 13(3). 433–441. 2 indexed citations
5.
Yao, Qiuming, Bin Wang, Peng Du, et al.. (2024). Increased interleukin-9 and Th9 cells in patients with refractory Graves’ disease and interleukin-9 polymorphisms are associated with autoimmune thyroid diseases. Frontiers in Immunology. 15. 1341749–1341749. 4 indexed citations
6.
Yu, Meixing, Jia Tang, Yanqing Huang, et al.. (2022). HOXA10 Regulates the Synthesis of Cholesterol in Endometrial Stromal Cells. Frontiers in Endocrinology. 13. 852671–852671. 14 indexed citations
7.
Wang, Weiwei, Liying Qiao, Jing Ren, et al.. (2022). Differences in the Association Between Modifiable Lifestyle Factors and Gastric Precancerous Lesions Among Mongolians and Han Chinese. Frontiers in Oncology. 12. 798829–798829. 3 indexed citations
8.
Du, Peng, Qiu Qin, Ronghua Song, et al.. (2022). High iodine promotes autoimmune thyroid disease by activating hexokinase 3 and inducing polarization of macrophages towards M1. Frontiers in Immunology. 13. 1009932–1009932. 10 indexed citations
9.
Du, Peng, et al.. (2022). Construction and Validation of Two Hepatocellular Carcinoma-Progression Prognostic Scores Based on Gene Set Variation Analysis. Frontiers in Cell and Developmental Biology. 10. 806989–806989. 3 indexed citations
10.
Qin, Qiu, et al.. (2021). Systemic Proteomic Analysis Reveals Distinct Exosomal Protein Profiles in Rheumatoid Arthritis. Journal of Immunology Research. 2021. 1–11. 16 indexed citations
11.
Du, Peng, et al.. (2020). Probiotics Can Boost the Antitumor Immunity of CD8 + T Cells in BALB/c Mice and Patients with Colorectal Carcinoma. Journal of Immunology Research. 2020(1). 4092472–4092472. 17 indexed citations
12.
Zhang, Guanying, Rui Yu, Xiangyang Chi, et al.. (2020). Tetanus vaccine-induced human neutralizing antibodies provide full protection against neurotoxin challenge in mice. International Immunopharmacology. 91. 107297–107297. 6 indexed citations
13.
14.
Li, Zhi, et al.. (2019). Transauricular arterial access for hepatic artery embolization in rabbit VX2 liver tumor. Journal of Cancer Research and Therapeutics. 15(2). 341–341. 1 indexed citations
15.
Yu, Xiaoyan, Long Feng, Xiaopeng Yang, et al.. (2018). A novel fully human anti-CD47 antibody as a potential therapy for human neoplasms with good safety. Biochimie. 151. 54–66. 14 indexed citations
16.
17.
Du, Peng, et al.. (2016). Immune Regulation and Antitumor Effect of TIM-1. Journal of Immunology Research. 2016. 1–6. 28 indexed citations
18.
Li, Xiaodong, Wenwei Hu, Chu Zhang, et al.. (2015). Emerging immune checkpoints for cancer therapy. Acta Oncologica. 54(10). 1706–1713. 37 indexed citations
19.
Li, Fei, et al.. (2011). Growth of G422 glioma implanted in the mouse brain was affected by the immune ability of the host.. PubMed. 124(13). 1994–8. 3 indexed citations
20.
Li, Jingjing, et al.. (2011). ApoB-100 and HSP60 Peptides Exert a Synergetic Role in Inhibiting Early Atherosclerosis in Immunized ApoE-null Mice. Protein and Peptide Letters. 18(7). 733–740. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Guo Breakdown of academic impact, for papers by Ke Zhu Breakdown of academic impact, for papers by Mengxi Sun Breakdown of academic impact, for papers by Bing Lin Breakdown of academic impact, for papers by Mengzhao Zhang Breakdown of academic impact, for papers by Yanyang Nan Breakdown of academic impact, for papers by Jiayi Li Breakdown of academic impact, for papers by Longfei Deng Breakdown of academic impact, for papers by Guiying Zhang
Rankless by CCL
2026